Subtype-Selective Dopamine Receptor Radioligands for PET Imaging: Current Status and Recent Developments

E-ISSN： 1875-533x|19|23|3957-3966

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.19, Iss.23, 2012-08, pp. : 3957-3966

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Developments of the PET Imaging Agents for Metabotropic Glutamate Receptor Subtype 5

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 18, 2007-09 ,pp. : 1800-1805

Bentham Science Publishers

Access to resources Recommend Favorite

Radioligands for the PET Imaging of Metabotropic Glutamate Receptor Subtype 5 (mGluR5)

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 15, 2010-10 ,pp. : 1558-1568

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in the Development of NR2B Subtype-Selective NMDA Receptor Antagonists

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 7, 2006-04 ,pp. : 697-709

Bentham Science Publishers

Access to resources Recommend Favorite

Neuropharmacological assessment of potential dopamine D 4 receptor-selective radioligands

By Kula N.S. Tarazi F.I. Baldessarini R.J. Xu L. Bakthavachalam V. Pounds S. True C.D.

European Journal of Pharmacology, Vol. 367, Iss. 1, 1999-02 ,pp. : 139-142

Elsevier

Access to resources Recommend Favorite

Recent Developments in Receptor-Selective Retinoids

Current Pharmaceutical Design, Vol. 6, Iss. 9, 2000-06 ,pp. : 919-931

Bentham Science Publishers

Access to resources Recommend Favorite